ArticleNAR genomics and bioinformatics2025
DRBP-EDP: classification of DNA-binding proteins and RNA-binding proteins using ESM-2 and dual-path neural network.
Article in NAR genomics and bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- MIF-MAPMS: Enhancing identification of myelin autoantigenic peptides in multiple sclerosis through multimodal information fusion.Protein science : a publication of the Protein Society · 2026Article
- Immunoinformatics-driven multi-epitope vaccine design as a promising strategy against multidrug-resistant pathogens: a comprehensive review.Folia microbiologica · 2026Review
- Sequence-Based Models for RNA-Protein Interactions Imputation Might Be Insufficient for Novel Signal Prediction in eCLIP Data.International journal of molecular sciences · 2026Article
- Interpretable prediction of nucleic acid-binding proteins using a protein language model.Bioinformatics advances · 2026Article
- DFL-MHC: MHC identification model based on dual-stage training and multi-view feature fusion.Frontiers in genetics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Regulation of DNA or RNA at the transcriptional, post-transcriptional, and translational levels are key steps in the central dogma of molecular biology. DNA-binding proteins (DBPs) and RNA-binding proteins (RBPs) play pivotal roles in the precise regulation of gene expression in these steps. Both of these two classes of proteins are nucleic acid-binding proteins (NABPs), so they exhibit significant similarity in both sequence and structure. However, traditional methods for identifying NABPs are typically time-consuming, costly, and challenging to scale up. Utilizing deep learning to classify proteins intelligently has emerged as a more efficient solution for these issues. In this study, we propose a phased classification method integrating ESM-2 with a dual-path neural network, called DRBP-EDP. Additionally, a refined approach to dataset construction is designed, resulting in the creation of high-quality protein classification datasets. The results demonstrated that the model achieved strong performance, with 90.03% accuracy in the first stage for classifying NABPs and non-nucleic acid-binding proteins, and 89.56% accuracy in the second stage for classifying DBPs and RBPs. To enhance accessibility and usability, DRBP-EDP has been developed in both executable and web-based versions, which are publicly available at https://doi.org/10.5281/zenodo.14092184 and https://github.com/MuQiang-MQ/DRBP-EDP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.